Q: Etomidate is contraindicated in patients with seizure disorders.
A) Yes
B) No
Answer: B
Conventionally, it is believed that etomidate is contraindicated in patients with seizures. This belief came from instances of post-etomidate myoclonus, which occurs in a few patients. Major side effects of etomidate include adrenal suppression, myoclonus, and evidence of regional cerebral excitation (nonclinical, EEG-specific) after intubation. Myoclonus is frequently misidentified as seizure activity. Etomidate is safe to use for the induction of patients with seizures and even in refractory status epilepticus. Postintubation sedation with propofol or a benzodiazepine prevents neuroexcitation.
Etomidate decreases cerebral blood flow and cerebral metabolic oxygen demand while preserving cerebral perfusion pressure.
#neurology
#pharmacology
#procedures
References:
1. Jellish WS, Riche H, Salord F, et al. Etomidate and thiopental-based anesthetic induction: comparisons between different titrated levels of electrophysiologic cortical depression and response to laryngoscopy. J Clin Anesth 1997; 9:36.
2. Oglesby AJ. Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department? Emerg Med J 2004; 21:655.
3. Reddy RV, Moorthy SS, Dierdorf SF, et al. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg 1993; 77:1008.